SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ChemTrak
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DeadHead who wrote (6)9/25/1996 1:54:00 PM
From: William Presti   of 48
 
I've been searching for news on CMTR as well. From what I can tell, the consensus was that the FDA approval on the HIV test kit was expected for September-October of this year. Add that to the introduction of the H pylori test kit this October at a trade show and, in my honest opinion, what you have here in CMTR is a greatly undervalued stock. Yes, there are already two other HIV kits on the market, but I feel that the market is large enough for at least three. Chemtrak will certainly nail down some desirable distribution channels. I would expect soon to see the stock heading back towards the 4-5 dollar range. It had been stable in this range with all the HIV competitor news factored into the price. On the revenue side, I would bet that the deal with Astra-Merck will bode very well for Chemtrak. Lastly, I finally went out and bought one of the Cholestrak cholesterol test kits. I was impressed at the ease of use. The whole package is very very well done.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News